WebSep 6, 2012 · CircuLite has obtained CE mark for its new micro-blood pump Synergy Circulatory Support system, designed to treat ambulatory heart failure patients (INTERMACS 4,5,6 / NYHA IIIB and early IV). The Synergy system, which is implanted using a mini-thoracotomy, is placed in a pacemaker-like pocket under the right … WebApr 21, 2015 · The Circulite Synergy Micro-pump was the first of such a device (1-3) ... Barbone A, Pini D, Rega F, et al. Circulatory support in elderly chronic heart failure patients using the CircuLite® Synergy® system. Eur J Cardiothorac Surg 2013;44:207-12; discussion 212.
CIRCULATE in Thesaurus: 1000+ Synonyms & Antonyms for …
WebJan 5, 2010 · Next-generation Synergy Micro-pumps include an endovascular system, a fully implantable system with physiological feedback, a right heart support system and a pediatric system. For more information on CircuLite and the Synergy Pocket Micro-pump devices, visit our website at www.CircuLite.net. CAUTION: Investigational Device. Webficult to obtain in vivo. In 10 patients implanted with a Circulite Synergy Micro-pump (HeartWare, Framingham, Massachusetts) (a continuous flow partial circulatory assist device connecting the left atrium to the right subclavian artery), transient CFD simulations were performed. Patients were divided into two groups depending on their cardiac output … draftsight cad software tutorial
CircuLite: Optimized Synergy® Circulatory Support System …
WebApr 21, 2015 · Partial mechanical circulatory support represents a new concept for the treatment of advanced heart failure. The Circulite Synergy Micro Pump®, where the inflow cannula is connected to the left atrium and the outflow cannula to the right subclavian artery, was one of the first devices to introduce this concept to the clinic. WebSep 10, 2012 · Company Recently Announced European CE Mark Approval for SYNERGY CircuLite®, Inc. today announced that the latest data from patients enrolled in the … WebMar 5, 2013 · CircuLite®, Inc. has today announced receipt of conditional approval from the U.S. FDA of an Investigational Device Exemption (IDE) for its lead product, the SYNERGY® Circulatory Support System. Synergy is a minimally-invasive device designed to reverse the symptoms of heart failure in ambulatory chronic heart failure patients. emily grande songs